10x Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TXG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Sep 26	SellUS$1,235,072	John Stuelpnagel	Individual	20,000	US$62.61
24 Aug 26	SellUS$1,168,775	Serge Saxonov	Individual	18,545	US$63.02
24 Aug 26	SellUS$1,081,853	Adam Taich	Individual	17,166	US$63.02
24 Aug 26	SellUS$870,860	Benjamin Hindson	Individual	13,818	US$63.02
11 Aug 26	SellUS$1,155,055	John Stuelpnagel	Individual	20,000	US$58.73
22 May 26	SellUS$283,399	Benjamin Hindson	Individual	11,595	US$24.44
22 May 26	SellUS$369,018	Adam Taich	Individual	15,098	US$24.44
22 May 26	SellUS$444,224	Serge Saxonov	Individual	18,175	US$24.44
23 Feb 26	SellUS$145,379	Benjamin Hindson	Individual	7,826	US$18.58
23 Feb 26	SellUS$166,593	Adam Taich	Individual	8,968	US$18.58
23 Feb 26	SellUS$178,928	Serge Saxonov	Individual	9,632	US$18.58
24 Nov 25	SellUS$157,363	Benjamin Hindson	Individual	8,283	US$19.00
24 Nov 25	SellUS$251,936	Serge Saxonov	Individual	13,261	US$19.00
24 Nov 25	SellUS$225,852	Adam Taich	Individual	11,888	US$19.00

Insider Trading Volume

Insider Buying: TXG insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TXG?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	940	0.000645%
Individual Insiders	10,185,954	6.99%
Institutions	135,482,414	93%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.2%	FMR LLC	18,521,492	US$1.4b	-0.6%	0.06%
11.8%	T. Rowe Price Group, Inc.	15,310,974	US$1.2b	164%	0.09%
8.29%	BlackRock, Inc.	10,804,070	US$827.6m	7.18%	0.01%
7.68%	ARK Investment Management LLC	10,003,058	US$766.2m	-14.6%	4.5%
5.36%	Vanguard Portfolio Management, LLC	6,982,492	US$534.9m	1.01%	0.02%
4.54%	Vanguard Capital Management, LLC	5,917,817	US$453.3m	-2.16%	0.01%
4.2%	Quantinno Capital Management LP	5,469,698	US$419.0m	1.07%	0.5%
3.22%	Amova Asset Management Co., Ltd.	4,194,627	US$321.3m	-17.9%	0.08%
3.18%	Serge Saxonov	4,136,873	US$316.9m	0.05%	no data
2.55%	Benjamin Hindson	3,322,697	US$254.5m	0.38%	no data
2.37%	Geode Capital Management, LLC	3,082,790	US$236.1m	6.15%	0.01%
2.15%	State Street Investment Management	2,801,437	US$214.6m	8.21%	0.01%
2.13%	Citadel Advisors LLC	2,779,213	US$212.9m	274%	0.13%
1.86%	John Stuelpnagel	2,427,550	US$186.0m	-1.53%	no data
1.71%	Dimensional Fund Advisors LP	2,225,284	US$170.5m	8.93%	0.02%
1.57%	The Goldman Sachs Group, Inc.	2,042,926	US$156.5m	-28%	0.03%
1.55%	Jacobs Levy Equity Management Inc	2,019,883	US$154.7m	-11.5%	0.55%
1.48%	AQR Capital Management, LLC	1,925,109	US$147.5m	-20.4%	0.05%
1.42%	Point72 Asset Management, L.P.	1,852,776	US$141.9m	0%	0.24%
1.4%	Morgan Stanley	1,819,959	US$139.4m	66.5%	0.01%
1.15%	Capital Research and Management Company	1,493,031	US$114.4m	2.8%	no data
1.06%	Eaton Vance Management	1,380,462	US$105.7m	-1.94%	0.02%
0.88%	Northern Trust Global Investments	1,144,027	US$87.6m	9.16%	0.01%
0.85%	Goldman Sachs Asset Management, L.P.	1,105,933	US$84.7m	-2.39%	0.01%
0.83%	Charles Schwab Investment Management, Inc.	1,087,150	US$83.3m	-3.54%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/21 01:47
End of Day Share Price	2026/09/21 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

10x Genomics, Inc. is covered by 26 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Luke Sergott	Barclays
Avantika Dhabaria	BofA Global Research
Michael Ryskin	BofA Global Research